383 — China Medical & HealthCare Cashflow Statement
0.000.00%
Last trade - 00:00- HK$738.48m
- HK$678.08m
- HK$1.57bn
Annual cashflow statement for China Medical & HealthCare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2019 June 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | — | -96.6 | -110 | -117 | — |
| Depreciation | |||||
| Non-Cash Items | — | 119 | 170 | 141 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -50.7 | -154 | 55 | -117 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -50.7 | -15.2 | 219 | 11.4 | — |
| Capital Expenditures | -44.4 | -100 | -154 | -138 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 11.1 | -22.8 | -30.6 | 39.3 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -33.3 | -123 | -185 | -98.6 | — |
| Financing Cash Flow Items | -55.8 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -48.5 | 109 | -79.1 | 88.9 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -132 | -26.7 | -40 | 12.6 | — |